MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program

Mind Cure Health has announced that it has developed a number of non-racemic mixtures of ibogaine and has filed a provisional patent for these mixtures and their therapeutic use in treating a range of central nervous system (CNS) disorders.

Category Press Release
Published in Mind Cure Health